Â¥
9.05
Nov 29
New Key Statistics Module, Z-Score and F-Score
SZSE:002644 Key Ratios
Market Cap ¥ M | 4,621.45 |
Enterprise Value ¥ M | 4,296.04 |
P/E(ttm) | 99.45 |
PE Ratio without NRI | 58.01 |
Forward PE Ratio | -- |
Price/Book | 2.61 |
Price/Sales | 4.64 |
Price/Free Cash Flow | 53.88 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.19 |
Revenue (TTM) ¥ M | 988.00 |
EPS (TTM) ¥ | 0.09 |
Beneish M-Score | -2.85 |
10-y EBITDA Growth Rate % | 10.20 |
5-y EBITDA Growth Rate % | 4.00 |
y-y EBITDA Growth Rate % | -64.50 |
EV-to-EBIT | 83.86 |
EV-to-EBITDA | 83.86 |
PEG | 14.50 |
Shares Outstanding M | 510.66 |
Net Margin (%) | 4.67 |
Operating Margin % | 10.22 |
Pre-tax Margin (%) | 5.19 |
Quick Ratio | 2.01 |
Current Ratio | 3.00 |
ROA % (ttm) | 1.84 |
ROE % (ttm) | 2.63 |
ROIC % (ttm) | 5.33 |
Dividend Yield % | 0.33 |
Altman Z-Score | 5.16 |
SZSE:002644 Number of Guru Trades
SZSE:002644 Volume of Guru Trades
Gurus Latest Trades with SZSE:002644
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002644 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lanzhou Foci Pharmaceutical Co Ltd Insider Transactions
No Available Data